These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 33825494)

  • 1. Merging Our Understanding of Anxiety and Exposure: Using Inhibitory Learning to Target Anxiety Sensitivity in Exposure Therapy.
    Bautista CL; Teng EJ
    Behav Modif; 2022 Jul; 46(4):819-833. PubMed ID: 33825494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exposure therapy augmentation: A review and extension of techniques informed by an inhibitory learning approach.
    Weisman JS; Rodebaugh TL
    Clin Psychol Rev; 2018 Feb; 59():41-51. PubMed ID: 29128146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory learning approaches to exposure therapy: A critical review and translation to obsessive-compulsive disorder.
    Jacoby RJ; Abramowitz JS
    Clin Psychol Rev; 2016 Nov; 49():28-40. PubMed ID: 27521505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maximizing exposure therapy: an inhibitory learning approach.
    Craske MG; Treanor M; Conway CC; Zbozinek T; Vervliet B
    Behav Res Ther; 2014 Jul; 58():10-23. PubMed ID: 24864005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing exposure therapy with an inhibitory retrieval approach and the OptEx Nexus.
    Craske MG; Treanor M; Zbozinek TD; Vervliet B
    Behav Res Ther; 2022 May; 152():104069. PubMed ID: 35325683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of avoidance behavior as an adjunct to exposure therapy: Insights from modern learning theory.
    Treanor M; Barry TJ
    Behav Res Ther; 2017 Sep; 96():30-36. PubMed ID: 28477845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How can neurobiology of fear extinction inform treatment?
    Craske MG; Sandman CF; Stein MB
    Neurosci Biobehav Rev; 2022 Dec; 143():104923. PubMed ID: 36280184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal models of fear relapse.
    Goode TD; Maren S
    ILAR J; 2014; 55(2):246-58. PubMed ID: 25225304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapse of anxiety-related fear and avoidance: Conceptual analysis of treatment with acceptance and commitment therapy.
    Smith BM; Smith GS; Dymond S
    J Exp Anal Behav; 2020 Jan; 113(1):87-104. PubMed ID: 31875982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cue Exposure Therapy for Alcohol Use Disorders: What Can Be Learned from Exposure Therapy for Anxiety Disorders?
    Byrne SP; Haber P; Baillie A; Giannopolous V; Morley K
    Subst Use Misuse; 2019; 54(12):2053-2063. PubMed ID: 31259660
    [No Abstract]   [Full Text] [Related]  

  • 11. Augmentation of Extinction and Inhibitory Learning in Anxiety and Trauma-Related Disorders.
    Lebois LAM; Seligowski AV; Wolff JD; Hill SB; Ressler KJ
    Annu Rev Clin Psychol; 2019 May; 15():257-284. PubMed ID: 30698994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fear extinction and relapse: state of the art.
    Vervliet B; Craske MG; Hermans D
    Annu Rev Clin Psychol; 2013; 9():215-48. PubMed ID: 23537484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain activation during fear extinction predicts exposure success.
    Ball TM; Knapp SE; Paulus MP; Stein MB
    Depress Anxiety; 2017 Mar; 34(3):257-266. PubMed ID: 27921340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of associative fear and avoidance learning in anxiety disorders: Gaps and directions for future research.
    Pittig A; Treanor M; LeBeau RT; Craske MG
    Neurosci Biobehav Rev; 2018 May; 88():117-140. PubMed ID: 29550209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of safety behaviors during exposure therapy for anxiety: Critical analysis from an inhibitory learning perspective.
    Blakey SM; Abramowitz JS
    Clin Psychol Rev; 2016 Nov; 49():1-15. PubMed ID: 27475477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Scarier the Better: Maximizing Exposure Therapy Outcomes for Spider Fear.
    Norberg MM; Newins AR; Jiang Y; Xu J; Forcadell E; Alberich C; Deacon BJ
    Behav Cogn Psychother; 2018 Nov; 46(6):754-760. PubMed ID: 30001760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose timing of D-cycloserine to augment cognitive behavioral therapy for social anxiety: Study design and rationale.
    Hofmann SG; Carpenter JK; Otto MW; Rosenfield D; Smits JA; Pollack MH
    Contemp Clin Trials; 2015 Jul; 43():223-30. PubMed ID: 26111923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing exposure therapy for anxiety disorders with glucocorticoids: from basic mechanisms of emotional learning to clinical applications.
    Bentz D; Michael T; de Quervain DJ; Wilhelm FH
    J Anxiety Disord; 2010 Mar; 24(2):223-30. PubMed ID: 19962269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rethinking avoidance: Toward a balanced approach to avoidance in treating anxiety disorders.
    Hofmann SG; Hay AC
    J Anxiety Disord; 2018 Apr; 55():14-21. PubMed ID: 29550689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The unique and conditional effects of interoceptive exposure in the treatment of anxiety: A functional analysis.
    Boettcher H; Barlow DH
    Behav Res Ther; 2019 Jun; 117():65-78. PubMed ID: 30579624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.